Tower Research Capital (TRC)’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,519
| Closed | -$10K | – | 6562 |
|
|
2023
Q1 | $10K | Sell |
5,519
-4,953
| -47% | -$8.97K | ﹤0.01% | 4454 |
|
|
2022
Q4 | $12K | Buy |
10,472
+2,895
| +38% | +$3.32K | ﹤0.01% | 3781 |
|
|
2022
Q3 | $18K | Sell |
7,577
-3,091
| -29% | -$7.34K | ﹤0.01% | 4043 |
|
|
2022
Q2 | $32K | Buy |
10,668
+8,586
| +412% | +$25.8K | ﹤0.01% | 3320 |
|
|
2022
Q1 | $14K | Buy |
2,082
+133
| +7% | +$894 | ﹤0.01% | 3940 |
|
|
2021
Q4 | $16K | Sell |
1,949
-3,553
| -65% | -$29.2K | ﹤0.01% | 3957 |
|
|
2021
Q3 | $41K | Sell |
5,502
-4,711
| -46% | -$35.1K | ﹤0.01% | 3120 |
|
|
2021
Q2 | $70K | Buy |
10,213
+5,141
| +101% | +$35.2K | ﹤0.01% | 2740 |
|
|
2021
Q1 | $52K | Sell |
5,072
-9,849
| -66% | -$101K | ﹤0.01% | 3098 |
|
|
2020
Q4 | $105K | Sell |
14,921
-6,374
| -30% | -$44.9K | ﹤0.01% | 2298 |
|
|
2020
Q3 | $173K | Buy |
21,295
+17,300
| +433% | +$141K | ﹤0.01% | 2704 |
|
|
2020
Q2 | $28K | Buy |
+3,995
| New | +$28K | ﹤0.01% | 3496 |
|
|
2020
Q1 | – | Sell |
-11,559
| Closed | -$101K | – | 4176 |
|
|
2019
Q4 | $101K | Sell |
11,559
-4,514
| -28% | -$39.4K | 0.01% | 938 |
|
|
2019
Q3 | $54K | Buy |
16,073
+13,763
| +596% | +$46.2K | ﹤0.01% | 1750 |
|
|
2019
Q2 | $11K | Buy |
2,310
+1,545
| +202% | +$7.36K | ﹤0.01% | 2529 |
|
|
2019
Q1 | $4K | Sell |
765
-7,160
| -90% | -$37.4K | ﹤0.01% | 3226 |
|
|
2018
Q4 | $26K | Buy |
7,925
+2,177
| +38% | +$7.14K | ﹤0.01% | 1751 |
|
|
2018
Q3 | $38K | Buy |
+5,748
| New | +$38K | ﹤0.01% | 1938 |
|
|
2018
Q2 | – | Sell |
-1,378
| Closed | -$31K | – | 4207 |
|
|
2018
Q1 | $31K | Buy |
1,378
+1,097
| +390% | +$24.7K | ﹤0.01% | 1959 |
|
|
2017
Q4 | $4K | Sell |
281
-3,325
| -92% | -$47.3K | ﹤0.01% | 3024 |
|
|
2017
Q3 | $56K | Buy |
+3,606
| New | +$56K | ﹤0.01% | 1855 |
|
|
2017
Q2 | – | Sell |
-3,357
| Closed | -$74K | – | 3761 |
|
|
2017
Q1 | $74K | Buy |
+3,357
| New | +$74K | 0.01% | 563 |
|